Rapidly Evolving SARS-CoV-2: A Brief Review Regarding the Variants and their Effects on Vaccine Efficacies

Shahid Nawaz1, Sara Janiad2, Aiman Fatima1

  • 1Institute of Microbiology and Molecular Genetics, University of the Punjab, Lahore, Pakistan.

PubMed

Insights

This review examines Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) features, variant development, and immune escape. It discusses how viral mutations impact vaccine efficacy against COVID-19.

Area of Science:

  • Virology
  • Immunology
  • Vaccinology

Background:

  • The COVID-19 pandemic caused by SARS-CoV-2 has led to millions of global deaths.
  • Mass vaccine development has significantly reduced transmission and infection rates worldwide.
  • Emerging SARS-CoV-2 variants raise concerns about current vaccine effectiveness.

Purpose of the Study:

  • To review key features of SARS-CoV-2, including its structure and genomics.
  • To explore the mechanisms behind the development of viral variants.
  • To discuss viral immune escape and its implications for vaccine strategies.

Main Methods:

  • Literature review of scientific publications on SARS-CoV-2.
  • Analysis of viral genomics and mutation patterns.
  • Discussion of immunological responses and vaccine platforms.

Main Results:

  • SARS-CoV-2 exhibits significant genomic variability, leading to the emergence of diverse variants.
  • Viral mutations can facilitate immune escape, potentially reducing vaccine efficacy.
  • Antigenic drift and shift are key mechanisms influencing variant evolution.

Conclusions:

  • Understanding SARS-CoV-2 variants and immune escape is crucial for ongoing pandemic control.
  • Continuous monitoring of viral evolution is necessary to adapt vaccine strategies.
  • Vaccine platforms must be adaptable to address emerging viral threats.

Related Concept Videos

Conjugated Proteins02:50

Conjugated Proteins

Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
18.3K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.1K
Vaccinations01:51

Vaccinations

Overview
44.5K
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.3K